Alzheimer’s Disease

To evaluate efficacy and safety in patients with mild to moderate Alzheimer’s Disease.

  • male or female 50-85 years or older
  • currently having memory problems.
  • currently taking a stable dose of    Donepezil & Memantine for 3 months
  • have a reliable caregiver
  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.